ReSound OMNIA RIE vs RxEars Rxi

The ReSound OMNIA RIE is a premium prescription behind-the-ear hearing aid released in 2022, currently available at $4,498. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.9/5, ranking #31 of 39 devices in the prescription hearing aid category. This device shows notable strengths in speech clarity for quiet environments, scoring 3.7/5—a solid result that sits 0.34 points above the category average. Own-voice comfort also performs above average at 3.0/5, which may appeal to users who find their own voice bothersome in other devices. Feedback handling is strong in absolute terms at 4.1/5, though it falls 0.62 points below the category average of 4.72/5. The OMNIA RIE's most significant limitation is speech in noise performance, scoring just 1.0/5—a low result that trails the category average by 1.11 points. For users who frequently encounter challenging listening environments like restaurants or group conversations, this represents a meaningful gap compared to alternatives. Music streaming scores a mixed 2.7/5, essentially matching the category average. The device offers flexible power options with both rechargeable and disposable batteries, plus streaming compatibility with iPhone and Android devices including hands-free functionality. However, at this premium price point, several competitors deliver stronger overall performance, including options from Phonak, Oticon, and Widex. The OMNIA RIE may suit users who prioritize quiet-environment clarity and own-voice comfort over noise-handling capabilities.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.